Itaru Ozeki

575 total citations
25 papers, 457 citations indexed

About

Itaru Ozeki is a scholar working on Hepatology, Epidemiology and Infectious Diseases. According to data from OpenAlex, Itaru Ozeki has authored 25 papers receiving a total of 457 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Hepatology, 15 papers in Epidemiology and 5 papers in Infectious Diseases. Recurrent topics in Itaru Ozeki's work include Hepatitis C virus research (12 papers), Hepatitis B Virus Studies (9 papers) and Liver Disease Diagnosis and Treatment (6 papers). Itaru Ozeki is often cited by papers focused on Hepatitis C virus research (12 papers), Hepatitis B Virus Studies (9 papers) and Liver Disease Diagnosis and Treatment (6 papers). Itaru Ozeki collaborates with scholars based in Japan, France and Italy. Itaru Ozeki's co-authors include Yoshiyasu Karino, Joji Toyota, Hiroyuki Kaneto, Takao Endo, Shigeru Sasaki, Fumio Itoh, Kohzoh Imai, Takefumi Kikuchi, Masaaki Satoh and Shouhei Iku and has published in prestigious journals such as SHILAP Revista de lepidopterología, Oncogene and Journal of Hepatology.

In The Last Decade

Itaru Ozeki

23 papers receiving 448 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Itaru Ozeki Japan 10 232 134 131 120 72 25 457
Yoon Jin Hwang South Korea 8 109 0.5× 49 0.4× 167 1.3× 74 0.6× 111 1.5× 18 399
H. Kurosawa Japan 8 158 0.7× 98 0.7× 141 1.1× 145 1.2× 136 1.9× 16 395
Xianjun Lao China 15 177 0.8× 94 0.7× 38 0.3× 74 0.6× 55 0.8× 29 406
Ayako Mabuchi Japan 12 122 0.5× 98 0.7× 103 0.8× 71 0.6× 76 1.1× 31 579
Ursula Lemberger Austria 8 74 0.3× 132 1.0× 159 1.2× 154 1.3× 132 1.8× 24 363
Naomi Funaki Japan 12 91 0.4× 84 0.6× 133 1.0× 114 0.9× 120 1.7× 25 389
Hiroyuki Nojima Japan 13 362 1.6× 138 1.0× 129 1.0× 123 1.0× 144 2.0× 41 647
Min Lian China 14 134 0.6× 46 0.3× 189 1.4× 286 2.4× 116 1.6× 34 575
Kyuichi Tanikawa Japan 5 78 0.3× 54 0.4× 182 1.4× 183 1.5× 41 0.6× 6 341

Countries citing papers authored by Itaru Ozeki

Since Specialization
Citations

This map shows the geographic impact of Itaru Ozeki's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Itaru Ozeki with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Itaru Ozeki more than expected).

Fields of papers citing papers by Itaru Ozeki

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Itaru Ozeki. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Itaru Ozeki. The network helps show where Itaru Ozeki may publish in the future.

Co-authorship network of co-authors of Itaru Ozeki

This figure shows the co-authorship network connecting the top 25 collaborators of Itaru Ozeki. A scholar is included among the top collaborators of Itaru Ozeki based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Itaru Ozeki. Itaru Ozeki is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ichihara, Shin, Tomohiro Arakawa, Tomoaki Nakajima, et al.. (2020). Bile duct adenoma: imaging features and radiologic–pathologic correlation. Japanese Journal of Radiology. 38(6). 561–571. 3 indexed citations
2.
Ozeki, Itaru, et al.. (2020). Predictors of hepatocellular carcinoma after hepatitis C virus eradication following direct-acting antiviral treatment: relationship with serum zinc. Journal of Clinical Biochemistry and Nutrition. 66(3). 245–252. 11 indexed citations
3.
Ozeki, Itaru, et al.. (2020). The association between serum zinc levels and subjective symptoms in zinc deficiency patients with chronic liver disease. Journal of Clinical Biochemistry and Nutrition. 66(3). 253–261. 3 indexed citations
4.
Ozeki, Itaru, Tomoaki Nakajima, Tomohiro Arakawa, et al.. (2019). Evaluation of treatment with zinc acetate hydrate in patients with liver cirrhosis complicated by zinc deficiency. Hepatology Research. 50(4). 488–501. 12 indexed citations
5.
Ozeki, Itaru, et al.. (2019). Zinc deficiency in patients with chronic liver disease in Japan. Hepatology Research. 50(3). 396–401. 17 indexed citations
6.
Ozeki, Itaru, Michihiro Yamaguchi, Takamitsu Arakawa, et al.. (2018). Recurrence of hepatocellular carcinoma in patients with a history of HCC after SVR to DAA for chronic hepatitis C. Journal of Hepatology. 68. S535–S535. 1 indexed citations
7.
Ozeki, Itaru, Tomohiro Arakawa, Tomoaki Nakajima, et al.. (2017). Safety of Sofosbuvir and Ribavirin Combination Therapy in a Patient Who Developed Anemia due to Ribavirin. SHILAP Revista de lepidopterología. 2017. 1–4. 1 indexed citations
8.
Ozeki, Itaru, Tomohiro Arakawa, Tomoaki Nakajima, et al.. (2017). A case of amebic liver abscess complicated by hepatic vein thrombus and pulmonary embolism. Kanzo. 58(10). 574–581. 1 indexed citations
9.
Ozeki, Itaru, Tomoaki Nakajima, Tomohiro Arakawa, et al.. (2017). Analysis of hepatitis B surface antigen (HBsAg) using high‐sensitivity HBsAg assays in hepatitis B virus carriers in whom HBsAg seroclearance was confirmed by conventional assays. Hepatology Research. 48(3). E263–E274. 20 indexed citations
11.
Ozeki, Itaru, et al.. (2015). P0997 : WFA+-M2BP is a predictive factor for fibrosis progression in NAFLD. Journal of Hepatology. 62. S721–S721. 1 indexed citations
13.
Toyota, J., Itaru Ozeki, Yoshiyasu Karino, et al.. (2012). Virological response and safety of 24‐week telaprevir alone in Japanese patients infected with hepatitis C virus subtype 1b. Journal of Viral Hepatitis. 20(3). 167–173. 8 indexed citations
14.
Karino, Yoshiyasu, Itaru Ozeki, Jouji Toyota, et al.. (2011). 1330 IL28B GENOTYPE MAJOR AND RELAPSE OF PREVIOUS PEG-IFN/RBV THERAPY ARE THE CONVINCING PREDICTOR OF SUSTAINED VIROLOGICAL RESPONSE IN TELAPREVIR WITH PEG-IFN/RBV THERAPY. Journal of Hepatology. 54. S525–S525. 2 indexed citations
15.
Ozeki, Itaru, Yoshiyasu Karino, Jun Akaike, et al.. (2011). Renal dysfunction in chronic hepatitis B patients treated with adefovir dipivoxil. Kanzo. 52(2). 102–111. 4 indexed citations
16.
Ozeki, Itaru, Jun Akaike, Yoshiyasu Karino, et al.. (2011). Antiviral effects of peginterferon alpha-2b and ribavirin following 24-week monotherapy of telaprevir in Japanese hepatitis C patients. Journal of Gastroenterology. 46(7). 929–937. 22 indexed citations
18.
Sasaki, Shigeru, Fumio Itoh, Takefumi Kikuchi, et al.. (2000). Frequent hypermethylation of CpG islands and loss of expression of the 14-3-3 σ gene in human hepatocellular carcinoma. Oncogene. 19(46). 5298–5302. 208 indexed citations
19.
Kaneto, Hiroyuki, Takao Endo, Itaru Ozeki, et al.. (2000). Macrocystic serous cystadenoma of the pancreas: importance of co-existent tiny cysts depicted by EUS. Journal of Gastroenterology. 35(6). 472–475. 19 indexed citations
20.
Sakamoto, Hirofumi, Itaru Ozeki, Toshiaki Sugaya, et al.. (1996). Subcapsular hematoma of the liver and pylethrombosis in the setting of cholestatic liver injury. Journal of Gastroenterology. 31(6). 880–884. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026